Analyst Estimates
BASF is widely covered by various German and international financial analysts, who provide their own research analyses and earnings estimates in respect of the company. On this page we provide you with the analyst estimates compiled monthly by Vara Research.
As before, BASF will neither be involved in the collection of the information nor in the compilation of the estimates; this will still be done independently by Vara Research.
The analyst estimates are exclusively based on the analyses of financial analysts who are independent from BASF. Any opinions, forecasts, estimates, projections or predictions regarding BASF’s performance (ultimately represented by the figures of the analyst estimates) given by the analysts only reflect their view and do not represent the opinions, forecasts, estimates, projections or predictions of BASF or its management.
BASF SE only renders the analyst estimates (average, high and low) compiled by Vara Research on this website. This does not imply that the company endorses, concurs with or adopts such information, conclusions or recommendations. BASF assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates, even if they differ from our own forecasts or expectations.
BASF Share
| € | Average | High | Low | ||
| Target share price | 51.86 | 63.00 | 41.00 | ||
BASF Group Estimates
| Million € | Average | High | Low |
| Sales | 18,582 | 20,253 | 17,370 |
| EBITDA before special items | 2,565 | 2,945 | 2,318 |
| EBITDA | 2,516 | 2,945 | 2,318 |
| EBIT before special items | 1,569 | 1,961 | 1,355 |
| EBIT | 1,547 | 1,961 | 1,355 |
| Income before income taxes | 1,436 | 1,766 | 1,253 |
| Net income | 1,081 | 1,332 | 890 |
| Earnings per Share (reported) (€) | 1.21 | 1.49 | 1.00 |
| Earnings per Share (adjusted) (€) | 1.41 | 1.93 | 1.10 |
| Million € | Average | High | Low |
| Sales | 17,221 | 18,191 | 16,133 |
| EBITDA before special items | 1,965 | 2,172 | 1,833 |
| EBITDA | 1,929 | 2,147 | 1,751 |
| EBIT before special items | 984 | 1,143 | 767 |
| EBIT | 958 | 1,133 | 792 |
| Income before income taxes | 797 | 1,031 | 518 |
| Net income | 559 | 787 | 292 |
| Earnings per Share (reported) (€) | 0.63 | 0.88 | 0.33 |
| Earnings per Share (adjusted) (€) | 0.75 | 0.91 | 0.67 |
| Million € | Average | High | Low |
| Sales | 69,338 | 71,322 | 66,704 |
| EBITDA before special items | 8,211 | 8,971 | 7,479 |
| EBITDA | 8,045 | 8,971 | 7,479 |
| EBIT before special items | 4,262 | 5,014 | 3,610 |
| EBIT | 4,106 | 5,014 | 3,519 |
| Income before income taxes | 3,531 | 5,007 | 2,507 |
| Net income | 2,560 | 3,675 | 1,807 |
| Earnings per Share (reported) (€) | 2.87 | 4.12 | 2.02 |
| Earnings per Share (adjusted) (€) | 3.33 | 4.12 | 1.48 |
| Dividend per Share (€) | 3.34 | 3.50 | 2.50 |
| Free cashflow | 388 | 1,297 | -108 |
| Million € | Average | High | Low |
| Sales | 72,311 | 73,811 | 69,938 |
| EBITDA before special items | 9,394 | 10,224 | 8,327 |
| EBITDA | 9,228 | 10,224 | 8,327 |
| EBIT before special items | 5,296 | 6,140 | 4,387 |
| EBIT | 5,168 | 6,140 | 4,387 |
| Income before income taxes | 4,536 | 5,738 | 3,346 |
| Net income | 3,292 | 4,256 | 2,474 |
| Earnings per Share (reported) (€) | 3.69 | 4.77 | 2.77 |
| Earnings per Share (adjusted) (€) | 4.20 | 5.36 | 3.17 |
| Dividend per Share (€) | 3.37 | 3.60 | 2.60 |
| Free cashflow | 1,604 | 4,408 | 394 |
| Million € | Average | High | Low |
| Sales | 75,064 | 80,981 | 72,159 |
| EBITDA before special items | 10,121 | 11,597 | 8,909 |
| EBITDA | 9,957 | 11,497 | 8,909 |
| EBIT before special items | 5,956 | 7,142 | 4,929 |
| EBIT | 5,819 | 6,946 | 4,929 |
| Income before income taxes | 5,203 | 6,805 | 4,057 |
| Net income | 3,809 | 5,191 | 3,027 |
| Earnings per Share (reported) (€) | 4.27 | 5.81 | 3.39 |
| Earnings per Share (adjusted) (€) | 4.83 | 6.74 | 3.63 |
| Dividend per Share (€) | 3.39 | 3.70 | 2.60 |
| Free cashflow | 3,390 | 4,955 | 726 |
Segment Estimates
Million € |
Average | High | Low |
| Chemicals | |||
Sales |
2,726 | 3,120 | 2,550 |
EBITDA before special items |
320 | 405 | 272 |
| Materials | |||
Sales |
3,619 | 4,106 | 3,337 |
EBITDA before special items |
397 | 471 | 288 |
| Industrial Solutions | |||
Sales |
2,088 | 2,211 | 1,982 |
EBITDA before special items |
303 | 556 | 236 |
| Surface Technologies | |||
Sales |
3,867 | 4,670 | 3,043 |
EBITDA before special items |
370 | 410 | 338 |
| Nutrition & Care | |||
Sales |
1,801 | 1,914 | 1,634 |
EBITDA before special items |
177 | 216 | 119 |
| Agricultural Solutions | |||
Sales |
3,593 | 4,066 | 3,191 |
EBITDA before special items |
1,220 | 1,329 | 1,100 |
| Other | |||
Sales |
884 | 1,340 | 620 |
EBITDA before special items |
-233 | -100 | -480 |
Million € |
Average | High | Low |
| Chemicals | |||
Sales |
2,721 | 2,930 | 2,599 |
EBITDA before special items |
373 | 415 | 330 |
| Materials | |||
Sales |
3,608 | 3,743 | 3,398 |
EBITDA before special items |
450 | 479 | 423 |
| Industrial Solutions | |||
Sales |
2,088 | 2,214 | 1,989 |
EBITDA before special items |
311 | 556 | 244 |
| Surface Technologies | |||
Sales |
3,977 | 4,311 | 3,345 |
EBITDA before special items |
366 | 404 | 332 |
| Nutrition & Care | |||
Sales |
1,749 | 1,916 | 1,679 |
EBITDA before special items |
181 | 214 | 138 |
| Agricultural Solutions | |||
Sales |
2,230 | 2,498 | 1,963 |
EBITDA before special items |
426 | 560 | 293 |
| Other | |||
Sales |
848 | 1,200 | 630 |
EBITDA before special items |
-142 | -27 | -444 |
Million € |
Average | High | Low |
| Chemicals | |||
Sales |
10,578 | 11,147 | 9,084 |
EBITDA before special items |
1,469 | 1,863 | 1,288 |
| Materials | |||
Sales |
14,397 | 14,781 | 13,937 |
EBITDA before special items |
1,807 | 2,068 | 1,709 |
| Industrial Solutions | |||
Sales |
8,221 | 8,557 | 8,010 |
EBITDA before special items |
1,063 | 1,199 | 556 |
| Surface Technologies | |||
Sales |
15,717 | 16,533 | 13,975 |
EBITDA before special items |
1,494 | 1,588 | 1,385 |
| Nutrition & Care | |||
Sales |
7,102 | 7,710 | 6,786 |
EBITDA before special items |
737 | 845 | 605 |
| Agricultural Solutions | |||
Sales |
9,884 | 10,546 | 9,337 |
EBITDA before special items |
2,091 | 2,370 | 1,938 |
| Other | |||
Sales |
3,229 | 3,628 | 2,480 |
EBITDA before special items |
-498 | 22 | -805 |
Million € |
Average | High | Low |
| Chemicals | |||
Sales |
11,156 | 12,658 | 9,344 |
EBITDA before special items |
1,737 | 2,130 | 1,435 |
| Materials | |||
Sales |
15,176 | 16,000 | 14,355 |
EBITDA before special items |
2,128 | 2,429 | 1,899 |
| Industrial Solutions | |||
Sales |
8,597 | 9,000 | 8,250 |
EBITDA before special items |
1,155 | 1,272 | 556 |
| Surface Technologies | |||
Sales |
16,176 | 17,270 | 14,954 |
EBITDA before special items |
1,619 | 1,788 | 1,423 |
| Nutrition & Care | |||
Sales |
7,416 | 7,940 | 7,121 |
EBITDA before special items |
885 | 1,100 | 670 |
| Agricultural Solutions | |||
Sales |
10,265 | 10,968 | 9,617 |
EBITDA before special items |
2,234 | 2,516 | 2,051 |
| Other | |||
Sales |
3,224 | 3,519 | 2,185 |
EBITDA before special items |
-499 | 197 | -845 |
Million € |
Average | High | Low |
| Chemicals | |||
Sales |
11,820 | 14,145 | 10,865 |
EBITDA before special items |
1,988 | 2,427 | 1,544 |
| Materials | |||
Sales |
15,853 | 17,200 | 14,786 |
EBITDA before special items |
2,345 | 2,797 | 2,008 |
| Industrial Solutions | |||
Sales |
8,914 | 9,500 | 8,498 |
EBITDA before special items |
1,222 | 1,360 | 556 |
| Surface Technologies | |||
Sales |
16,498 | 17,803 | 15,157 |
EBITDA before special items |
1,687 | 1,987 | 1,386 |
| Nutrition & Care | |||
Sales |
7,739 | 8,202 | 7,383 |
EBITDA before special items |
1,013 | 1,341 | 725 |
| Agricultural Solutions | |||
Sales |
10,632 | 11,407 | 9,906 |
EBITDA before special items |
2,315 | 2,642 | 2,105 |
| Other | |||
Sales |
2,959 | 3,623 | -34 |
EBITDA before special items |
-599 | -400 | -1,010 |
Disclaimer: This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.
